Literature DB >> 28461190

Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?

Krishna Rao1, Vincent B Young2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28461190      PMCID： PMC5754213          DOI： 10.1053/j.gastro.2017.04.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  19 in total

1.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

2.  The risk for Clostridium difficile colitis during hospitalization in asymptomatic carriers.

Authors:  S Kagan; Y Wiener-Well; E Ben-Chetrit; L Kashat; J Aouizerats; T Bdolah-Abram; A M Yinnon; M V Assous
Journal:  J Hosp Infect       Date:  2017-01-30       Impact factor: 3.926

3.  Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection.

Authors:  Johan S Bakken
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

4.  Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis.

Authors:  Ken Kato; Nobusada Funabashi; Hiroyuki Takaoka; Hiroki Kohno; Takashi Kishimoto; Yukio Nakatani; Goro Matsumiya; Yoshio Kobayashi
Journal:  Int J Cardiol       Date:  2016-09-03       Impact factor: 4.164

Review 5.  New and emerging therapies for Clostridium difficile infection.

Authors:  Jessica Martin; Mark Wilcox
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

6.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

Review 7.  Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.

Authors:  Bradley C Johnston; Stephanie S Y Ma; Joshua Z Goldenberg; Kristian Thorlund; Per O Vandvik; Mark Loeb; Gordon H Guyatt
Journal:  Ann Intern Med       Date:  2012-12-18       Impact factor: 25.391

8.  Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Authors:  Yves Longtin; Bianka Paquet-Bolduc; Rodica Gilca; Christophe Garenc; Elise Fortin; Jean Longtin; Sylvie Trottier; Philippe Gervais; Jean-François Roussy; Simon Lévesque; Debby Ben-David; Isabelle Cloutier; Vivian G Loo
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

9.  Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.

Authors:  Jennifer L Kuntz; David H Smith; Amanda F Petrik; Xiuhai Yang; Micah L Thorp; Tracy Barton; Karen Barton; Matthew Labreche; Steven J Spindel; Eric S Johnson
Journal:  Perm J       Date:  2016

Review 10.  Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review.

Authors:  Lynne V McFarland
Journal:  Antibiotics (Basel)       Date:  2015-04-13
View more
  3 in total

Review 1.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

Review 2.  Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications.

Authors:  Racha El Hage; Emma Hernandez-Sanabria; Tom Van de Wiele
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

3.  A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis.

Authors:  Rita D Shelby; Grace E Janzow; Lauren Mashburn-Warren; Jeffrey Galley; Natalie Tengberg; Jason Navarro; Miriam Conces; Michael T Bailey; Steven D Goodman; Gail E Besner
Journal:  Gut Microbes       Date:  2020-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.